Clinical Trial

Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)

Study acronym: LM
Recruiting
View on ClinicalTrials.gov →
Summary
The prospective study LOCATION MATTERS aims to investigate the radiation-induced damage to the heart and the cardiovascular system in patients treated with thoracic radiotherapy. Patients enrolled in the study will complete a set of extensive measures at the baseline, end of RT, and 9 months after treatment. Ultrasound exams, CT scans, pulmonary tests and wearable devices will assess functional and morphological parameters and the association with their variation and the dose delivered to the heart substructures and to the normal lung.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-08.
Trial Details
NCT Number NCT06361784
Lead Sponsor Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Collaborators: Politecnico di Milano
Conditions Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment 150 participants
Start Date 2024-03-29
Primary Completion 2029-03-29 (estimated)
Study Completion 2029-03-29 (estimated)
Updated on ClinicalTrials.gov 2024-04-15